Sumatriptan suppositories for the acute treatment of migraine

International Journal of Clinical Practice

Volumn 52, Issue 1, 1998, Pages 31-35

  Tepper, S J ^a   Cochran, A ^b   Hobbs, S ^b   Woessner, M ^b   Saiers, Jane ^b  

^a Glaxo Wellcome ^*

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; RECURRENCE RISK; SIDE EFFECT; SUPPOSITORY; TIME; VOMITING;

ADMINISTRATION, RECTAL; ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NAUSEA; SEROTONIN ANTAGONISTS; SUMATRIPTAN; SUPPOSITORIES; VOMITING;

EID: 0031984196     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Eng J Med 1991; 325: 316-321.
2. Cady RK, Wendt JK, Kirchner JF et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991; 265: 2831-2835.
3. Oral Sumatriptan Dose-Defining Study Group. Sumatriptan - an oral dose-defining study. Eur Neurol 1991; 31: 300-305.
4. Oral Sumatriptan International Multiple-Dose Study Group. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol 1991; 31: 306-313.
5. Pfaffenrath V, Cunin G, Sjonell G et al. Efficacy and safety of sumatriptan tablets in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache. In press.
6. Ryan R, Elkind A, Baker CC et al. Sumatriptan nasal spray for the acute treatment of migraine: results of two clinical studies. Neurology 1997; 49: 1225-1230.
7. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: 1-96.
8. Nappi G, Sicuteri F, Byrne M et al. Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol 1994; 241: 138-144.
9. Cady RK, Rubino J, Crummett D, Littlejohn T. Oral sumatriptan in the treatment of recurrence headache. Arch Fam Med 1994; 3: 766-772.
10. Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine. Eur Neurol 1991; 31: 314-322.
11. Oral Sumatriptan and Aspirin Plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 1992; 32: 177-184.